#lipid-nanoparticle-technology

[ follow ]
#patent-dispute-settlement #mrna-covid-19-vaccines #moderna-licensing #patent-settlement
Intellectual property law
fromMedCity News
1 day ago

Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology - MedCity News

Moderna settles a patent dispute with Arbutus Biopharma and Genevant Sciences for $950 million upfront plus potentially over $1 billion more, acknowledging their lipid nanoparticle technology's role in Covid-19 vaccine development.
fromIPWatchdog.com | Patents & Intellectual Property Law
1 day ago

Moderna Settles with Genevant and Arbutus, Ending LNP Patent Dispute

The settlement resolves all U.S. and international patent litigation concerning the unauthorized use of Genevant's and Arbutus' lipid nanoparticle (LNP) delivery technology in Moderna's COVID-19 vaccines. The agreement came just days before a highly anticipated jury trial was scheduled to begin in the U.S. District Court for the District of Delaware.
Intellectual property law
[ Load more ]